The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease). | J Clin Endocrinol Metab;109(10): e1938-e1939, 2024 Sep 16. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease).

Dayan, Colin M.

Affiliation

Dayan CM; Thyroid Research Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

J Clin Endocrinol Metab ; 109(10): e1938-e1939, 2024 Sep 16.

Article in En | MEDLINE | ID: mdl-38451776

Subject(s)

Graves Ophthalmopathy; Humans; Graves Ophthalmopathy/therapy

Key words

FcRn; Graves disease; Graves orbitopathy; clinical trial; thyroid eye disease; thyroid stimulating immunoglobulins

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Graves Ophthalmopathy Limits: Humans Language: En Journal: J Clin Endocrinol Metab Year: 2024 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Graves Ophthalmopathy Limits: Humans Language: En Journal: J Clin Endocrinol Metab Year: 2024 Document type: Article Affiliation country: United kingdom Country of publication: United States